SMAD7 and rheumatoid arthritis: As expected, the CD-1 Smad7 WT mice did not develop any syndromes of RA (Figure 3A and Supplementary Figure 2A), which is consistent with previous reports that the CD-1 mice are resistant to CIA or collagen antibody-induced arthritis(CAIA) (25–28).